• Science and Research

  CF: Orkambi Reimbursement Approved in France for Patients 2 or Older

  Posted by cystic-fibrosis-news-moderator on December 4, 2019 at 8:22 am

  

  French authorities have approved national reimbursement of Orkambi for cystic fibrosis patients 2 or older, with two copies of the F508del mutation. Click here to read more about it.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 4 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply